🇫🇷
France · FR · FR:67969992
KALETRA 200 mg/50 mg, comprimé pelliculé
ReimbursedATC J05AE
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerABBVIE DEUTSCHLAND (ALLEMAGNE)
CountryFR (France)
ATC codeJ05AE
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 2
- cip1334009376099371 flacon(s) polyéthylène haute densité (PEHD) de 120 comprimé(s)EUR 180.37
- cip13340094940964810 plaquette(s) PVC fluoropolymère de 12 comprimé(s)EUR 180.37
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67969992",
"date_amm": "2006-06-27",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/01/172",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code J05AE.
- IEAptivusBoehringer Ingelheim International GmbH
- 🇺🇸DarunavirNuCare Pharmaceuticals, Inc.
- 🇺🇸DarunavirAurobindo Pharma Limited
- 🇺🇸DarunavirAurobindo Pharma Limited
- 🇺🇸DARUNAVIRLupin Pharmaceuticals, Inc.
- 🇺🇸DARUNAVIRLupin Pharmaceuticals, Inc.
- 🇺🇸EVOTAZE.R. Squibb & Sons, L.L.C.
- GBEvotaz 300mg/150mg tabletsBristol-Myers Squibb Pharmaceuticals Ltd
Access this data programmatically
Query KALETRA 200 mg/50 mg, comprimé pelliculé and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.